Deal date

KANDO id: 242317

Financial Transaction:

Series C


Elixir Pharmaceuticals Inc



Round participants

Country Notes

CDIB Ventures

United States Initial investment.

JAFCO Ventures Inc

United States Initial investment.

MPM Capital

United States Initial investment.

Oxford Bioscience Partners

(OBP)
United States Initial investment.

YFY Biotech Management Co

Taiwan Initial investment.